WSYR Syracuse on MSN8h
New FDA-approved non-opioid pain killerNewsChannel 9 at 5 p.m.
For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...
Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...
Professor Dame Ijeoma Uchegbu discusses the nanoparticle delivery system behind the non-addictive pain medication Envelta and ...
Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...
A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...
CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...
The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.
Fentanyl has emerged as the primary cause of illicit drug deaths in Canada and the United States, and its trafficking has ...
The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.
Robert F. Kennedy Jr.’s HHS nomination moves to a full Senate vote; Donald Trump’s tariff war sparks China-related concerns for biopharma; Pfizer, Merck and more announce Q4 and 2024 earnings; and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results